These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 29843897)

  • 1. Major bleeding with old and novel oral anticoagulants: How to manage it. Focus on reversal agents.
    Di Fusco SA; Lucà F; Benvenuto M; Iorio A; Fiscella D; D'Ascenzo F; Madeo A; Colivicchi F; Di Lenarda A; Gulizia MM
    Int J Cardiol; 2018 Oct; 268():75-79. PubMed ID: 29843897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Major bleeding with old and novel oral anticoagulants: How to manage it. Focus on general measures.
    Di Fusco SA; Lucà F; Benvenuto M; Iorio A; Fiscella D; D'Ascenzo F; Madeo A; Colivicchi F; Di Lenarda A; Gulizia MM
    Int J Cardiol; 2018 Oct; 268():80-84. PubMed ID: 29853278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reversal Agents for the Direct Oral Anticoagulants.
    Ansell JE
    Hematol Oncol Clin North Am; 2016 Oct; 30(5):1085-98. PubMed ID: 27637309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prothrombin complex concentrate for vitamin K antagonist reversal in acute bleeding settings: efficacy and safety.
    Ostermann H; von Heymann C
    Expert Rev Hematol; 2019 Jul; 12(7):525-540. PubMed ID: 31159607
    [No Abstract]   [Full Text] [Related]  

  • 5. Four-factor prothrombin complex concentrate versus plasma for urgent vitamin K antagonist reversal: new evidence.
    Sarode R
    Clin Lab Med; 2014 Sep; 34(3):613-21. PubMed ID: 25168946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New strategies for effective treatment of vitamin K antagonist-associated bleeding.
    Yates SG; Sarode R
    J Thromb Haemost; 2015 Jun; 13 Suppl 1():S180-6. PubMed ID: 26149021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacologic interventions for reversing the effects of oral anticoagulants.
    Kalus JS
    Am J Health Syst Pharm; 2013 May; 70(10 Suppl 1):S12-21. PubMed ID: 23640528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Practical management of bleeding in patients receiving non-vitamin K antagonist oral anticoagulants.
    Weitz JI; Pollack CV
    Thromb Haemost; 2015 Nov; 114(6):1113-26. PubMed ID: 26155974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Race against the clock: overcoming challenges in the management of anticoagulant-associated intracerebral hemorrhage.
    Le Roux P; Pollack CV; Milan M; Schaefer A
    J Neurosurg; 2014 Aug; 121 Suppl():1-20. PubMed ID: 25081496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Warfarin reversal.
    Hanley JP
    J Clin Pathol; 2004 Nov; 57(11):1132-9. PubMed ID: 15509671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Warfarin anticoagulation reversal: management of the asymptomatic and bleeding patient.
    Makris M; van Veen JJ; Maclean R
    J Thromb Thrombolysis; 2010 Feb; 29(2):171-81. PubMed ID: 19882303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New direct oral anticoagulants--current therapeutic options and treatment recommendations for bleeding complications.
    Miesbach W; Seifried E
    Thromb Haemost; 2012 Oct; 108(4):625-32. PubMed ID: 22782297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reversal of vitamin K antagonists prior to urgent surgery.
    Grobler C; Callum J; McCluskey SA
    Can J Anaesth; 2010 May; 57(5):458-67. PubMed ID: 20077167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct Oral Anticoagulant- or Warfarin-Related Major Bleeding: Characteristics, Reversal Strategies, and Outcomes From a Multicenter Observational Study.
    Xu Y; Schulman S; Dowlatshahi D; Holbrook AM; Simpson CS; Shepherd LE; Wells PS; Giulivi A; Gomes T; Mamdani M; Khuu W; Frymire E; Johnson AP;
    Chest; 2017 Jul; 152(1):81-91. PubMed ID: 28219635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intracerebral hemorrhage in patients receiving oral anticoagulation therapy.
    da Silva IR; Provencio JJ
    J Intensive Care Med; 2015 Feb; 30(2):63-78. PubMed ID: 23753250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid reversal of warfarin-associated hemorrhage in the emergency department by prothrombin complex concentrates.
    Frumkin K
    Ann Emerg Med; 2013 Dec; 62(6):616-626.e8. PubMed ID: 23829955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of treatment-related fluid overload reduces estimated effective cost of prothrombin complex concentrate in patients requiring rapid vitamin K antagonist reversal.
    Jones CA; Ducis K; Petrozzino J; Clark E; Fung MK; Peters C; Sarkar IN; Krol E; Pochal B; Boutrus A; Weimersheimer P; Freeman K
    Expert Rev Pharmacoecon Outcomes Res; 2016; 16(1):135-9. PubMed ID: 26211539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Bleeding risk and perioperative management of patients anticoagulated with vitamin K antagnosists].
    Angelo M; Stockner I; Wiedermann CJ
    Wien Med Wochenschr; 2008; 158(21-22):615-20. PubMed ID: 19052707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of bleeding with oral anticoagulants in patients with atrial fibrillation.
    Bosch J; Eikelboom JW
    Hamostaseologie; 2015; 35(4):351-7. PubMed ID: 26013362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specific antidotes against direct oral anticoagulants: A comprehensive review of clinical trials data.
    Tummala R; Kavtaradze A; Gupta A; Ghosh RK
    Int J Cardiol; 2016 Jul; 214():292-8. PubMed ID: 27082776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.